首页> 外文期刊>Chinese Medical Journal >A five-year follow-up study on the pathological changes of gastric mucosa after H .pylori eradication
【24h】

A five-year follow-up study on the pathological changes of gastric mucosa after H .pylori eradication

机译:根除幽门螺杆菌后胃黏膜病理变化的五年随访研究

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Objectives To investigate the relationship between H. Pylori infection, gastric cancer and other gastric diseases through the changes in gastric mucosa and the status of different gastric diseases within 5 years after H. Pylori eradication in H. Pylori-positive subjects in a high incidence region of gastric cancer.Methods One thousand and six adults were selected from the general population in Yantai, Shandong province, a high incidence region for gastric cancer in China. Gastroscopy and Campylobacter-like organism (CLO) testing were performed on all subjects. Biopsy samples from the gastric antrum and body were obtained for histology and assessment of H. Pylori infection. All H. Pylori-positive subjects were then randomly divided into two groups: treatment group receiving Omeprazole Amoxicillin Clarythromycin (OAC) triple therapy and placebo as controls. These subjects were endoscopically followed up in the second and fifth year. We compared the endoscopic appearance and histology of the biopsy specimens from the same site obtained at the first and last visits.Results All 552 H. Pylori-positive subjects were randomly and evenly divided into treatment group or control group. During the five-year follow-up, the numbers of patients who continued to be negative or positive for H. Pylori were 161 and 198, respectively. Statistical analysis revealed that: 1. At the initial visit, there were no significant differences in the severity and activity of inflammation, atrophy and intestinal metaplasia between the biopsy specimens from the antrum and body respectively in both groups. 2. The severity and activity of inflammation in both the antrum and body were markedly reduced after H. Pylori eradication ( P = 0.000). 3. Within five years after H. Pylori eradication, intestinal metaplasia in the antrum either regressed or had no progression, while the proportion of intestinal metaplasia in the H. Pylori-positive group increased significantly ( P = 0.032). 4. After H. Pylori eradication, the atrophy in both the antrum and body had no significant regression. The P value was 0.223 and 0.402, respectively. Conculsions H. Pylori eradication results in remarkable reduction in the severity and activity of chronic gastritis, marked resolution of intestinal metaplasia in the antrum. On the other hand, continuous H. Pylori infection leads to progressive aggravation of atrophy and intestinal metaplasia.
机译:目的通过高发地区幽门螺杆菌阳性患者根除幽门螺杆菌后的5年内,通过胃黏膜的变化和幽门螺杆菌阳性者的不同胃病状况,调查幽门螺杆菌感染,胃癌等胃病的关系。方法从山东省烟台市(中国胃癌高发地区)的总人口中选出106名成年人。对所有受试者进行胃镜检查和弯曲杆菌样生物(CLO)测试。从胃窦和胃的活检标本中获取组织学和幽门螺杆菌感染的评估。然后将所有幽门螺杆菌阳性受试者随机分为两组:接受奥美拉唑阿莫西林克拉霉素(OAC)三联疗法和安慰剂作为对照组的治疗组。在第二年和第五年对这些对象进行内窥镜随访。我们比较了第一次和最后一次就诊时从同一部位获得的活检标本的内窥镜外观和组织学。结果将所有552例H. Pylori阳性受试者随机且均匀地分为治疗组或对照组。在五年的随访中,幽门螺杆菌持续阴性或阳性的患者分别为161和198。统计分析表明:1.初次就诊时,两组胃窦和身体活检标本的炎症,萎缩和肠化生的严重程度和活性均无明显差异。 2.根除幽门螺杆菌后,胃腔和体内炎症的严重性和活动性均明显降低(P = 0.000)。 3.根除幽门螺杆菌后的五年内,胃窦的肠上皮化生变质或无进展,而幽门螺杆菌阳性组的肠上皮化生比例显着增加(P = 0.032)。 4.根除幽门螺杆菌后,胃窦和身体的萎缩均无明显消退。 P值分别为0.223和0.402。连续性H.幽门螺旋杆菌根除可显着降低慢性胃炎的严重程度和活性,显着缓解肠腔内肠上皮化生。另一方面,持续的幽门螺杆菌感染导致萎缩和肠化生的进行性加重。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号